dishman pharma (emkay) Demand Recovery Underway

Dishman's Indian CRAMS business to see some respite as supplies to European customer set to begin from Q1FY12 leading to higher operating leverage
Date Rating Target Price Recommendation Price Broker house
11 Apr 2011 accumulate (from hold) 125 102 emkay Report

No comments:

Post a Comment